China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
000999
Peringkat dalam Saham
#2914
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a prominent... China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a prominent pharmaceutical enterprise engaged in the research, development, manufacturing, and distribution of medicinal products. Its operations span both the People's Republic of China and international markets, additionally providing various health-related services. The company's extensive product line includes a wide range of over-the-counter (OTC) medications addressing common conditions such as colds, skin issues, gastrointestinal complaints, coughs, and needs in orthopedics and pediatrics. It also provides prescription drugs, with a focus on areas like traditional Chinese medicine, oncology, cardiovascular and cerebrovascular health, digestive system disorders, orthopedics, and pediatrics. Further offerings comprise Chinese medicine injections, specialized formula granules, and anti-infective agents. These products are often marketed under popular brand families, notably 999 family medicine, Sanjiuweitai series, 999 Ganmaoling series, and 999 dermatitis series. Founded in 1999 and headquartered in Shenzhen, PRC, the company initially operated as Sanjiu Pharmaceutical Co., Ltd. before rebranding to its current name in February 2010. It functions as a subsidiary under the umbrella of China Resources (Holdings) Co., Ltd.
Harga Saham
$3.74
Kapitalisasi Pasar
$6.23B
Perubahan (1 hari)
-2.11%
Perubahan (1 tahun)
-8.54%
Negara
CN
Perdagangan China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999)
Kategori
Healthcare
Laba untuk China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999)
Laba pada Jun 2026 TTM: $714.70M
Menurut laporan keuangan terbaru dari China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., laba saat ini perusahaan adalah $714.70M. Pada tahun 2024, perusahaan memperoleh laba sebesar $629.34M, peningkatan dibandingkan laba tahun 2023 sebesar $530.39M. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. dari 2001 hingga 2026
Laba pada akhir setiap tahun
| Tahun | Laba | Mengubah |
|---|---|---|
| 2026 (TTM) | $714.70M | 2.80% |
| 2025 | $695.23M | 10.47% |
| 2024 | $629.34M | 18.65% |
| 2023 | $530.39M | 37.94% |
| 2022 | $384.52M | 21.98% |
| 2020 | $315.25M | -14.08% |
| 2019 | $366.92M | 46.83% |
| 2018 | $249.89M | 7.08% |
| 2017 | $233.36M | 11.49% |
| 2016 | $209.31M | -11.11% |
| 2015 | $235.46M | 15.78% |
| 2014 | $203.36M | -9.34% |
| 2013 | $224.32M | 8.45% |
| 2012 | $206.84M | 37.53% |
| 2011 | $150.40M | -4.00% |
| 2010 | $156.66M | 18.25% |
| 2009 | $132.48M | 39.94% |
| 2008 | $94.67M | 79.81% |
| 2007 | $52.65M | 60.01% |
| 2006 | $32.90M | 52.20% |
| 2005 | $21.62M | -126.33% |
| 2004 | $-82.11M | -349.03% |
| 2003 | $32.97M | 44.24% |
| 2002 | $22.86M | 11.09% |
| 2001 | $20.58M | 0.00% |
Laba untuk perusahaan serupa atau pesaing
| Perusahaan | Laba | Perbedaan Laba | Negara |
|---|---|---|---|
| $3.62B | 406.21% |
DE
|
|
| $3.40B | 376.42% |
DE
|
|
| $1.72B | 141.17% |
JP
|
|
| $930.30M | 30.17% |
CH
|
|
| $1.69B | 136.83% |
IN
|
